Ardelyx, Inc. (ARDX) vs Beta Bionics, Inc. (BBNX)
A side-by-side comparison of Ardelyx, Inc. and Beta Bionics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ARDX
Ardelyx, Inc.
$3.29HealthcareDelayed quote: Oct 6, 2026, 2:50 PM EDT
BBNX
Beta Bionics, Inc.
$18.64HealthcareDelayed quote: Oct 6, 2026, 2:49 PM EDT
Total return — ARDX vs BBNX
growth of $100 · dividends reinvested · last 2yARDX -38.3% (-21.4%/yr)BBNX -19.8% (-10.4%/yr)BBNX compounded faster over this window
ARDX BBNX
ARDX vs BBNX: by the numbers
- •BBNX is the larger company ($839M vs $813M market cap).
- •Both run net losses; ARDX's is the smaller (-12.35% vs -61.32% net margin).
Metrics side by side
Valuation
| Metric | ARDX | BBNX |
|---|---|---|
| P/S ratio | 1.80 | 7.05 |
| P/B ratio | 5.45 | 3.27 |
Profitability
| Metric | ARDX | BBNX |
|---|---|---|
| Gross margin | 93.96% | 58.31% |
| Operating margin | -7.86% | -69.75% |
| Net margin | -12.35% | -61.32% |
| ROE | -37.38% | -28.46% |
| ROIC | -7.99% | -31.17% |
Growth (annualized)
| Metric | ARDX | BBNX |
|---|---|---|
| Revenue CAGR (5Y) | 105.14% | N/A |
| Total return CAGR (5Y) | 20.95% | N/A |
Go deeper
Dig into the metrics
Ardelyx ROEBeta Bionics ROEArdelyx operating marginBeta Bionics operating marginArdelyx revenue growthBeta Bionics revenue growthArdelyx free cash flowBeta Bionics free cash flow
Ardelyx & Beta Bionics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.